Loyola University Chicago’s Cardinal Bernardin Cancer Center is committed to developing innovative treatments, discovering the underlying causes of cancer, and training the next generation of physicians and scientists.
An expanding research hub on the university’s Health Sciences Campus, the Cancer Center has a team of physician- and basic-scientists seeking to identify strategies to prevent, diagnose, and treat cancer.
This multidisciplinary approach applies the best thinking from research bench to bedside and beyond. For example, Loyola scientists have studied the role of the immune system in fighting cancer. They were the first in Chicago to engineer CAR-T cells from an individual’s T cells. This “living drug,” produced in a state-of-the-art onsite lab, is a potentially curative treatment for leukemia and lymphoma.
The Cancer Center’s robust clinical trials program runs an average of nearly 300 clinical trials annually. These trials are important paths to discovery for new treatments.
Training the Next Generation
Loyola’s Stritch School of Medicine faculty members are dedicated to helping the scientists of tomorrow push the boundaries of science. Together, they search for the next, life-changing breakthroughs. Stritch students work alongside nationally recognized scientists and physicians, many who have published groundbreaking research in leading journals. The STAR program (Student Training in Approaches to Research) is a research education program where medical students are fully engaged in research with the guidance of a research mentor. At the undergraduate level, the Oncology Summer Research Internship is a highly competitive program for Loyola undergraduates who work alongside Cancer Center scientists. These programs highlight the innovative research training supported at Loyola’s Health Sciences Campus.
For more information about Loyola University Chicago’s Cardinal Bernardin Cancer Center or Stritch School of Medicine, visit loyola.edu.